Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt: A Five-Year Multicenter Study

Figure 6

OS according to protocols of treatment. The estimated OS rate was 48.9%  ±  9.6 and 76.9%  ±  15.3 for patients on VAC and CWS protocol, respectively. While mean OS time was 42.6 months ±5.9 and 22 months ±1.7 for patients on VAC and CWS protocol, respectively.